Related Experiment Video
Updated: Jun 6, 2026
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
Analysis of Her2/neu membrane protein clusters in different types of breast cancer cells using localization
R Kaufmann1, P Müller, G Hildenbrand
1Applied Optics and Information Processing, Kirchhoff-Institute for Physics, University Heidelberg, Im Neuenheimer Feld, Heidelberg, Germany. kaufmann@kip.uni-heidelberg.de
Abstract:
The Her2/neu tyrosine kinase receptor is a member of the epidermal growth factor family. It plays an important role in tumour genesis of certain types of breast cancer and its overexpression correlates with distinct diagnostic and therapeutic decisions. Nevertheless, it is still under intense investigation to improve diagnostic outcome and therapy control. In this content, we applied spectral precision distance/position determination microscopy, a technique based on the general principles of localization microscopy in order to study tumour typical conformational changes of receptor clusters on cell membranes. We examined two different mamma carcinoma cell lines as well as cells of a breast biopsy of a healthy donor. The Her2/neu receptor sites were labelled by immunofluorescence using conventional fluorescent dyes (Alexa conjugated antibodies). The characterization of the Her2/neu distribution on plasma membrane sections of 176 different cells yielded a total amount of 20 637 clusters with a mean diameter of 67 nm. Statistical analysis on the single molecule level revealed differences in clustering of Her2/neu between all three different cell lines. We also showed that using spectral precision distance/position determination microscopy, a dual colour reconstruction of the 3D spatial arrangement of Her2/neu and Her3 is possible. This indicates that spectral precision distance/position determination microscopy could be used as an enhanced tool offering additional information of Her2/neu receptor status.
Insights
Spectral precision distance/position determination microscopy reveals distinct Her2/neu receptor clustering in breast cancer cells. This advanced technique offers enhanced insights into Her2/neu status for improved diagnostics and therapy.
Area of Science:
- Cell Biology
- Biophysics
- Oncology
Background:
- The Her2/neu tyrosine kinase receptor is crucial in epidermal growth factor family signaling.
- Her2/neu overexpression is significant in breast cancer genesis, impacting diagnostic and therapeutic strategies.
- Improving diagnostic outcomes and therapy control for Her2/neu-driven cancers remains an active research area.
Purpose of the Study:
- To investigate tumor-typical conformational changes of Her2/neu receptor clusters on cell membranes.
- To evaluate the utility of spectral precision distance/position determination microscopy (spdPM) for studying receptor clustering.
- To compare Her2/neu clustering in different cell lines and healthy donor tissue.
Main Methods:
- Application of spectral precision distance/position determination microscopy (spdPM), a localization microscopy technique.
- Immunofluorescence labeling of Her2/neu receptor sites using Alexa-conjugated antibodies.
- Analysis of Her2/neu distribution in two mamma carcinoma cell lines and healthy donor breast tissue.
Main Results:
- Characterization of 20,637 Her2/neu clusters with a mean diameter of 67 nm across 176 cells.
- Statistical analysis revealed significant differences in Her2/neu clustering among the three cell types.
- Demonstrated dual-color reconstruction of 3D spatial arrangements for Her2/neu and Her3 using spdPM.
Conclusions:
- Spectral precision distance/position determination microscopy (spdPM) effectively visualizes Her2/neu receptor clustering.
- spdPM reveals distinct clustering patterns indicative of cellular differences.
- This technique provides enhanced information on Her2/neu receptor status, potentially improving diagnostic and therapeutic applications.
More Related Videos
11:34Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
06:51Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry
Published on: November 14, 2025